Montreux Equity Partners is a private investment firm dedicated to building great healthcare companies. Our mission is to generate industry leading returns by investing in superior businesses that meet the most compelling healthcare needs of tomorrow.
Montreux invests in opportunities in which we add value beyond the commitment of capital. Our operating philosophy is anchored in a foundation of honesty, integrity, and uncompromising professionalism. Montreux is currently investing out of their fourth fund, MEP IV, a $250 M fund.
|Pivot Medical||11/11||Series C||$32M||4|
|GC Aesthetics||10/10||Venture Round||$30M||1|
|Tobira Therapeutics||9/10||Series B||$31M||5|
|Avantis Medical Systems||6/10||Debt||$2.1M||1|
|Transcept Pharmaceuticals||3/07||Series D||$40M||8|
|Avantis Medical Systems||11/06||Series B||$12M||2|